Amha Gebremedhin (Am Gebremedhin)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

High Throughput

Chronic Myeloid Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kshitij Srivastava, Qinan Yin, Addisalem Taye Makuria, Maria Rios, Amha Gebremedhin, Willy Albert Flegel
CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities. Transfusion 64 (7) (2024)
Kshitij Srivastava, Qinan Yin, Addisalem Taye Makuria, Maria Rios, Amha Gebremedhin, Willy Albert Flegel
CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities. Transfusion 64 (7) (2024)
Kshitij Srivastava, Qinan Yin, Addisalem Taye Makuria, Maria Rios, Amha Gebremedhin, Willy Albert Flegel
CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities. Transfusion (2024)
Kshitij Srivastava, Qinan Yin, Addisalem Taye Makuria, Maria Rios, Amha Gebremedhin, Willy Albert Flegel
CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities. Transfusion 64 (7) (2024)
Atalay Mulu Fentie, Fishatsion Tadesse, Ephrem Engidawork, Amha Gebremedhin
Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian's with chronic myeloid leukemia. PloS one 14 (3) (2019)
Jana Feuchtner, Assefa Mathewos, Asmare Solomon, Genebo Timotewos, Abreha Aynalem, Tigeneh Wondemagegnehu, Amha Gebremedhin, Fekadu Adugna, Mirko Griesel, Andreas Wienke, Adamu Addissie, Ahmedin Jemal, Eva Johanna Kantelhardt
Addis Ababa population-based pattern of cancer therapy, Ethiopia. PloS one 14 (9) (2019)